How Has the Disseminated Intravascular Coagulation DIC Market Evolved Historically and What is its Current Size?
The disseminated intravascular coagulation dic market has seen considerable growth due to a variety of factors.
• In recent times, the market size for disseminated intravascular coagulation (DIC) has experienced substantial growth. An expansion from $0.46 billion in 2024 to $0.49 billion in 2025, representing a compound annual growth rate (CAGR) of 5.3% is anticipated. Factors like an increase in sepsis, a surge in trauma cases, a rise in cancer incidence, escalated healthcare spending, improved awareness among healthcare professionals, and an increased uptake of targeted therapies contribute to the growth observed in the historic period.
What is the Forecasted Market Size and CAGR for the Disseminated Intravascular Coagulation DIC Market?
The disseminated intravascular coagulation dic market is expected to maintain its strong growth trajectory in upcoming years.
• Over the upcoming years, strong expansion is predicted for the disseminated intravascular coagulation (DIC) market. By 2029, it's projected to reach a worth of $0.59 billion with a 5.0% compound annual growth rate (CAGR). The augmentation during the forecast timeline can be associated with higher utilization of targeted therapies, increased emphasis on early diagnosis of diseases, escalated investments in medical infrastructure, growing clinical research about coagulopathy remedies, and amplified recognition of uncommon blood disorders. Notable trends expected during this period include the refinement of diagnostic tests, incorporation of innovative anticoagulant treatments, personalized medical strategies, AI-based diagnostic systems, improved patient tracking technologies, and the creation of tailored treatments.
What Key Factors and Trends Are Driving The Growth Disseminated Intravascular Coagulation DIC Market?
The rapid rise in cancer occurrences is believed to stimulate the expansion of the disseminated intravascular coagulation (DIC) market. Defined by the unchecked multiplication and invasion of abnormal cells, cancer can cause detrimental damage to normal tissues. The elevated cancer rates are attributable to environmental exposure, lifestyle transformations, aging population, infections, and genetic tendencies. Disseminated intravascular coagulation (DIC) is a result of cancer activating the coagulation cascades excessively through cancer-produced procoagulant substances, culminating in widespread clotting and bleeding. For instance, data by the National Cancer Institute, an American government institution, shows that there were approximately 20 million fresh cancer instances and 9.7 million fatalities from cancer across the globe in 2022. Predictions indicate that these figures could rise to 29.9 million new cases and 15.3 million deaths each year by 2040. Hence, the burgeoning spread of cancer is fueling the expansion of the disseminated intravascular coagulation (DIC) market.
What Are The Market Segments In The Disseminated Intravascular Coagulation DIC Market?
The disseminated intravascular coagulation (DIC) market covered in this report is segmented –
1) By Treatment: Medicines, Transfusions, Surgery, Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam, Partial Thromboplastin Time (PTT), Fibrinogen Blood Test, D-dimer, Other Diagnoses
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Medicines: Anticoagulants, Antiplatelet Drugs, Fibrinolytics, Procoagulants, Antithrombin Therapy
2) By Transfusions: Platelet Transfusion, Fresh Frozen Plasma (FFP), Cryoprecipitate Transfusion, Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus, Organ Surgery
4) By Other Treatments: Plasma Exchange, Supportive Care, Steroid Therapy
Pre-Book The Disseminated Intravascular Coagulation DIC Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Disseminated Intravascular Coagulation DIC Market?
Leading firms in the disseminated intravascular coagulation (DIC) market are concentrating on the enhancement of coagulation diagnostic technologies, such as next-level blood clotting tests. These high-tech tools elevate the precision, speed, and simplicity of DIC diagnosis, facilitating swift medical interventions and improved health outcomes for patients. The term next-generation blood clotting tests refers to sophisticated diagnostic techniques and tools, developed to analyze blood coagulation more comprehensively, efficiently, and accurately than conventional tests. An example of this is the expansion of the cardiovascular testing portfolio by LumiraDx Limited, a healthcare company based in the UK, in June 2022. This expansion was made possible through CE Mark approvals for its NT-proBNP and enhanced D-Dimer tests, amplifying the LumiraDx Platform's capacity to aid physicians in diagnosing heart failure and eliminating venous thromboembolism at the point of care. These progressions strive to enhance the early detection and treatment of cardiovascular and thrombotic conditions, including disseminated intravascular coagulation (DIC).
Who Are the Key Players In The Disseminated Intravascular Coagulation DIC Market?
Major companies operating in the disseminated intravascular coagulation (DIC) market are:
• Nihon Kohden Corporation
• Pfizer Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• AbbVie Inc.
• Merck & Co. Inc.
• Bayer AG
• Sanofi S.A.
• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• Thermo Fisher Scientific Inc.
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Danaher Corporation
• Eli Lily and Company
• Siemens Healthineers
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Grifols S.A.
• Eisai Co. Ltd.
• Beckman Coulter Inc.
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
What Are The Regional Insights Into The Disseminated Intravascular Coagulation DIC Market?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in the disseminated intravascular coagulation (DIC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
